Loading…
Methods of DNA adduct determination and their application to testing compounds for genotoxicity
At the International Workshop on Genotoxicity Test Procedures (IWGTP) held in Washington, DC (March 25–26, 1999), a working group considered the uses of DNA adduct determination methods for testing compounds for genotoxicity. When a drug or chemical displays an unusual or inconsistent combination of...
Saved in:
Published in: | Environmental and molecular mutagenesis 2000, Vol.35 (3), p.222-233 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4529-908cddb009cb11171bc8499dd1fbd9ecbf9ef42f9fd8c08b6743d436255082083 |
container_end_page | 233 |
container_issue | 3 |
container_start_page | 222 |
container_title | Environmental and molecular mutagenesis |
container_volume | 35 |
creator | Phillips, D. H. Farmer, P. B. Beland, F. A. Nath, R. G. Poirier, M. C. Reddy, M. V. Turteltaub, K. W. |
description | At the International Workshop on Genotoxicity Test Procedures (IWGTP) held in Washington, DC (March 25–26, 1999), a working group considered the uses of DNA adduct determination methods for testing compounds for genotoxicity. When a drug or chemical displays an unusual or inconsistent combination of positive and negative results in in vitro and in vivo genotoxicity assays and/or in carcinogenicity experiments, investigations into whether or not DNA adducts are formed may be helpful in assessing whether or not the test compound is a genotoxin. DNA adduct determinations can be carried out using radiolabeled compounds and measuring radioactive decay (scintillation counting) or isotope ratios (accelerator mass spectrometry) in the isolated DNA. With unlabeled compounds adducts may be measured by 32P‐postlabeling analysis of the DNA, or by physicochemical methods including mass spectrometry, fluorescence spectroscopy, or electrochemical detection, or by immunochemical methods. Each of these approaches has different strengths and limitations, influenced by sensitivity, cost, time, and interpretation of results. The design of DNA binding studies needs to be on a case‐by‐case basis, depending on the compound's profile of activity. DNA purity becomes increasingly important the more sensitive, and less chemically specific, the assay. While there may be adduct levels at which there is no observable biological effect, there are at present insufficient data on which to set a threshold level for biological significance. Environ. Mol. Mutagen. 35:222–233, 2000 © 2000 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1098-2280(2000)35:3<222::AID-EM9>3.0.CO;2-E |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17550592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17550592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4529-908cddb009cb11171bc8499dd1fbd9ecbf9ef42f9fd8c08b6743d436255082083</originalsourceid><addsrcrecordid>eNp9kO9rEzEcxg9RXJ3-C3IvRLYXV79J7leqCKWrtWNbKyqDvfmSS3Jb9HqplxTX_94cV6Yw8FV4kg9PHj5RxAmMCQB9d_J1OVueEuBlQmkJJxQATlk2YR8opZPJdHmWzC_5RzaG8Wz1nibzJ9HogX4ajaDkLMlzTo-iF879ACAk5fR5dESgYAXPilGEl9rfWeViW8dnV9NYKLWTPlba625jWuGNbWPRqtjfadPFYrttjBxuvY29dt60t7G0m63dtaGmtl18q1vr7b2Rxu9fRs9q0Tj96nAeR98_zb_NPicXq8VyNr1IZJpRnnAopVIVAJcVIaQglSxTzpUidaW4llXNdZ3SmteqlFBWeZEylbKcZhmUFEp2HL0dered_bULs3BjnNRNI1ptdw5JEciM0wB-GUDZWec6XeO2MxvR7ZEA9tYRe-vYe8TeI_bWkWXIQgyvwToG6yECzlZIcR46Xx8-31Ubrf5pHDQH4M0BEE6Kpu5EK437y7EsZYwEbD1gv02j94-G_XfX41l9DJXJUGmc1_cPlaL7iXkYl-H11QLXN9fn-WJ9jjfsD0ZNt80</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17550592</pqid></control><display><type>article</type><title>Methods of DNA adduct determination and their application to testing compounds for genotoxicity</title><source>Wiley-Blackwell Journals</source><source>Wiley-Blackwell Read & Publish Collection</source><creator>Phillips, D. H. ; Farmer, P. B. ; Beland, F. A. ; Nath, R. G. ; Poirier, M. C. ; Reddy, M. V. ; Turteltaub, K. W.</creator><creatorcontrib>Phillips, D. H. ; Farmer, P. B. ; Beland, F. A. ; Nath, R. G. ; Poirier, M. C. ; Reddy, M. V. ; Turteltaub, K. W.</creatorcontrib><description>At the International Workshop on Genotoxicity Test Procedures (IWGTP) held in Washington, DC (March 25–26, 1999), a working group considered the uses of DNA adduct determination methods for testing compounds for genotoxicity. When a drug or chemical displays an unusual or inconsistent combination of positive and negative results in in vitro and in vivo genotoxicity assays and/or in carcinogenicity experiments, investigations into whether or not DNA adducts are formed may be helpful in assessing whether or not the test compound is a genotoxin. DNA adduct determinations can be carried out using radiolabeled compounds and measuring radioactive decay (scintillation counting) or isotope ratios (accelerator mass spectrometry) in the isolated DNA. With unlabeled compounds adducts may be measured by 32P‐postlabeling analysis of the DNA, or by physicochemical methods including mass spectrometry, fluorescence spectroscopy, or electrochemical detection, or by immunochemical methods. Each of these approaches has different strengths and limitations, influenced by sensitivity, cost, time, and interpretation of results. The design of DNA binding studies needs to be on a case‐by‐case basis, depending on the compound's profile of activity. DNA purity becomes increasingly important the more sensitive, and less chemically specific, the assay. While there may be adduct levels at which there is no observable biological effect, there are at present insufficient data on which to set a threshold level for biological significance. Environ. Mol. Mutagen. 35:222–233, 2000 © 2000 Wiley‐Liss, Inc.</description><identifier>ISSN: 0893-6692</identifier><identifier>EISSN: 1098-2280</identifier><identifier>DOI: 10.1002/(SICI)1098-2280(2000)35:3<222::AID-EM9>3.0.CO;2-E</identifier><identifier>PMID: 10737957</identifier><identifier>CODEN: EMMUEG</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>32P-postlabeling ; Biological and medical sciences ; Chemical mutagenesis ; DNA adducts ; DNA Adducts - analysis ; endogenous DNA damage ; genotoxicity ; immunoassay ; mass spectrometry ; Mass Spectrometry - methods ; Medical sciences ; Mutagenicity Tests ; Phosphorus Radioisotopes ; radioactivity ; Sensitivity and Specificity ; Toxicology</subject><ispartof>Environmental and molecular mutagenesis, 2000, Vol.35 (3), p.222-233</ispartof><rights>Copyright © 2000 Wiley‐Liss, Inc.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright 2000 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4529-908cddb009cb11171bc8499dd1fbd9ecbf9ef42f9fd8c08b6743d436255082083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2280%282000%2935%3A3%3C222%3A%3AAID-EM9%3E3.0.CO%3B2-E$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2280%282000%2935%3A3%3C222%3A%3AAID-EM9%3E3.0.CO%3B2-E$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,1417,4024,4050,4051,23930,23931,25140,27923,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1354331$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10737957$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phillips, D. H.</creatorcontrib><creatorcontrib>Farmer, P. B.</creatorcontrib><creatorcontrib>Beland, F. A.</creatorcontrib><creatorcontrib>Nath, R. G.</creatorcontrib><creatorcontrib>Poirier, M. C.</creatorcontrib><creatorcontrib>Reddy, M. V.</creatorcontrib><creatorcontrib>Turteltaub, K. W.</creatorcontrib><title>Methods of DNA adduct determination and their application to testing compounds for genotoxicity</title><title>Environmental and molecular mutagenesis</title><addtitle>Environ. Mol. Mutagen</addtitle><description>At the International Workshop on Genotoxicity Test Procedures (IWGTP) held in Washington, DC (March 25–26, 1999), a working group considered the uses of DNA adduct determination methods for testing compounds for genotoxicity. When a drug or chemical displays an unusual or inconsistent combination of positive and negative results in in vitro and in vivo genotoxicity assays and/or in carcinogenicity experiments, investigations into whether or not DNA adducts are formed may be helpful in assessing whether or not the test compound is a genotoxin. DNA adduct determinations can be carried out using radiolabeled compounds and measuring radioactive decay (scintillation counting) or isotope ratios (accelerator mass spectrometry) in the isolated DNA. With unlabeled compounds adducts may be measured by 32P‐postlabeling analysis of the DNA, or by physicochemical methods including mass spectrometry, fluorescence spectroscopy, or electrochemical detection, or by immunochemical methods. Each of these approaches has different strengths and limitations, influenced by sensitivity, cost, time, and interpretation of results. The design of DNA binding studies needs to be on a case‐by‐case basis, depending on the compound's profile of activity. DNA purity becomes increasingly important the more sensitive, and less chemically specific, the assay. While there may be adduct levels at which there is no observable biological effect, there are at present insufficient data on which to set a threshold level for biological significance. Environ. Mol. Mutagen. 35:222–233, 2000 © 2000 Wiley‐Liss, Inc.</description><subject>32P-postlabeling</subject><subject>Biological and medical sciences</subject><subject>Chemical mutagenesis</subject><subject>DNA adducts</subject><subject>DNA Adducts - analysis</subject><subject>endogenous DNA damage</subject><subject>genotoxicity</subject><subject>immunoassay</subject><subject>mass spectrometry</subject><subject>Mass Spectrometry - methods</subject><subject>Medical sciences</subject><subject>Mutagenicity Tests</subject><subject>Phosphorus Radioisotopes</subject><subject>radioactivity</subject><subject>Sensitivity and Specificity</subject><subject>Toxicology</subject><issn>0893-6692</issn><issn>1098-2280</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp9kO9rEzEcxg9RXJ3-C3IvRLYXV79J7leqCKWrtWNbKyqDvfmSS3Jb9HqplxTX_94cV6Yw8FV4kg9PHj5RxAmMCQB9d_J1OVueEuBlQmkJJxQATlk2YR8opZPJdHmWzC_5RzaG8Wz1nibzJ9HogX4ajaDkLMlzTo-iF879ACAk5fR5dESgYAXPilGEl9rfWeViW8dnV9NYKLWTPlba625jWuGNbWPRqtjfadPFYrttjBxuvY29dt60t7G0m63dtaGmtl18q1vr7b2Rxu9fRs9q0Tj96nAeR98_zb_NPicXq8VyNr1IZJpRnnAopVIVAJcVIaQglSxTzpUidaW4llXNdZ3SmteqlFBWeZEylbKcZhmUFEp2HL0dered_bULs3BjnNRNI1ptdw5JEciM0wB-GUDZWec6XeO2MxvR7ZEA9tYRe-vYe8TeI_bWkWXIQgyvwToG6yECzlZIcR46Xx8-31Ubrf5pHDQH4M0BEE6Kpu5EK437y7EsZYwEbD1gv02j94-G_XfX41l9DJXJUGmc1_cPlaL7iXkYl-H11QLXN9fn-WJ9jjfsD0ZNt80</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Phillips, D. H.</creator><creator>Farmer, P. B.</creator><creator>Beland, F. A.</creator><creator>Nath, R. G.</creator><creator>Poirier, M. C.</creator><creator>Reddy, M. V.</creator><creator>Turteltaub, K. W.</creator><general>John Wiley & Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>2000</creationdate><title>Methods of DNA adduct determination and their application to testing compounds for genotoxicity</title><author>Phillips, D. H. ; Farmer, P. B. ; Beland, F. A. ; Nath, R. G. ; Poirier, M. C. ; Reddy, M. V. ; Turteltaub, K. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4529-908cddb009cb11171bc8499dd1fbd9ecbf9ef42f9fd8c08b6743d436255082083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>32P-postlabeling</topic><topic>Biological and medical sciences</topic><topic>Chemical mutagenesis</topic><topic>DNA adducts</topic><topic>DNA Adducts - analysis</topic><topic>endogenous DNA damage</topic><topic>genotoxicity</topic><topic>immunoassay</topic><topic>mass spectrometry</topic><topic>Mass Spectrometry - methods</topic><topic>Medical sciences</topic><topic>Mutagenicity Tests</topic><topic>Phosphorus Radioisotopes</topic><topic>radioactivity</topic><topic>Sensitivity and Specificity</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phillips, D. H.</creatorcontrib><creatorcontrib>Farmer, P. B.</creatorcontrib><creatorcontrib>Beland, F. A.</creatorcontrib><creatorcontrib>Nath, R. G.</creatorcontrib><creatorcontrib>Poirier, M. C.</creatorcontrib><creatorcontrib>Reddy, M. V.</creatorcontrib><creatorcontrib>Turteltaub, K. W.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Environmental and molecular mutagenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phillips, D. H.</au><au>Farmer, P. B.</au><au>Beland, F. A.</au><au>Nath, R. G.</au><au>Poirier, M. C.</au><au>Reddy, M. V.</au><au>Turteltaub, K. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methods of DNA adduct determination and their application to testing compounds for genotoxicity</atitle><jtitle>Environmental and molecular mutagenesis</jtitle><addtitle>Environ. Mol. Mutagen</addtitle><date>2000</date><risdate>2000</risdate><volume>35</volume><issue>3</issue><spage>222</spage><epage>233</epage><pages>222-233</pages><issn>0893-6692</issn><eissn>1098-2280</eissn><coden>EMMUEG</coden><abstract>At the International Workshop on Genotoxicity Test Procedures (IWGTP) held in Washington, DC (March 25–26, 1999), a working group considered the uses of DNA adduct determination methods for testing compounds for genotoxicity. When a drug or chemical displays an unusual or inconsistent combination of positive and negative results in in vitro and in vivo genotoxicity assays and/or in carcinogenicity experiments, investigations into whether or not DNA adducts are formed may be helpful in assessing whether or not the test compound is a genotoxin. DNA adduct determinations can be carried out using radiolabeled compounds and measuring radioactive decay (scintillation counting) or isotope ratios (accelerator mass spectrometry) in the isolated DNA. With unlabeled compounds adducts may be measured by 32P‐postlabeling analysis of the DNA, or by physicochemical methods including mass spectrometry, fluorescence spectroscopy, or electrochemical detection, or by immunochemical methods. Each of these approaches has different strengths and limitations, influenced by sensitivity, cost, time, and interpretation of results. The design of DNA binding studies needs to be on a case‐by‐case basis, depending on the compound's profile of activity. DNA purity becomes increasingly important the more sensitive, and less chemically specific, the assay. While there may be adduct levels at which there is no observable biological effect, there are at present insufficient data on which to set a threshold level for biological significance. Environ. Mol. Mutagen. 35:222–233, 2000 © 2000 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10737957</pmid><doi>10.1002/(SICI)1098-2280(2000)35:3<222::AID-EM9>3.0.CO;2-E</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-6692 |
ispartof | Environmental and molecular mutagenesis, 2000, Vol.35 (3), p.222-233 |
issn | 0893-6692 1098-2280 |
language | eng |
recordid | cdi_proquest_miscellaneous_17550592 |
source | Wiley-Blackwell Journals; Wiley-Blackwell Read & Publish Collection |
subjects | 32P-postlabeling Biological and medical sciences Chemical mutagenesis DNA adducts DNA Adducts - analysis endogenous DNA damage genotoxicity immunoassay mass spectrometry Mass Spectrometry - methods Medical sciences Mutagenicity Tests Phosphorus Radioisotopes radioactivity Sensitivity and Specificity Toxicology |
title | Methods of DNA adduct determination and their application to testing compounds for genotoxicity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methods%20of%20DNA%20adduct%20determination%20and%20their%20application%20to%20testing%20compounds%20for%20genotoxicity&rft.jtitle=Environmental%20and%20molecular%20mutagenesis&rft.au=Phillips,%20D.%20H.&rft.date=2000&rft.volume=35&rft.issue=3&rft.spage=222&rft.epage=233&rft.pages=222-233&rft.issn=0893-6692&rft.eissn=1098-2280&rft.coden=EMMUEG&rft_id=info:doi/10.1002/(SICI)1098-2280(2000)35:3%3C222::AID-EM9%3E3.0.CO;2-E&rft_dat=%3Cproquest_cross%3E17550592%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4529-908cddb009cb11171bc8499dd1fbd9ecbf9ef42f9fd8c08b6743d436255082083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17550592&rft_id=info:pmid/10737957&rfr_iscdi=true |